epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Journal Article Synopsis

JACC Adv

25m

Why cutting saturated fat helps some patients more than others

Genetics may help explain why LDL cholesterol responds dramatically to diet in some people and barely changes in others. . .
Journal Article Synopsis

Obesity

2h

Briefer walks best for glucose control

One long walk or several short ones? Spacing exercise throughout the day may be optimal. . .
Journal Article Synopsis

GOLD

3h

GOLD 2027: LAMAs now preferred for Group A COPD

The annual update also expands CT imaging recommendations and incorporates emerging biologic therapies. . .
Journal Article Synopsis

JAMA Health Forum

5h

SNAP benefit cut tied to more chronic pain

The largest US food assistance program was built to cover groceries, but the end of its pandemic-era boost tracked with more pain among likely participants. . .

Journal Article Synopsis

Cochrane Database Syst Rev

7h

After a COPD flare, rehab may help patients stay out of hospital

A Cochrane review finds stronger evidence for better quality of life and exercise capacity than for preventing readmissions or death. . .
Journal Article Synopsis

JAMA Netw Open

9h

More precise allergy alerts shift antibiotic use

A risk-stratified electronic health record approach also reduced use of some alternative antibiotics. . .

Internally Generated Content

ObesityWeek 2026

11h

Two-year trial adds evidence for phentermine in obesity care

Weight loss persisted, with no average rise in blood pressure among participants. . .
Government Health Agency News

FDA

19h

FDA OKs Wilserdly with everolimus for ESR1-mutated advanced breast cancer

Median progression-free survival was 4.5 months longer versus a standard hormone-based combination. . .

Journal Article Synopsis

Ann Allergy Asthma Immunol

20h

ACAAI 2026: Could GLP-1 drugs help curb asthma flares?

A meta-analysis links use to 27% lower exacerbation risk in patients with obesity, but evidence remains observational. . .

Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information